The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The federal Project Grant award of $1,576,368 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) will fund an evaluation of electrical stimulation during nerve transfer surgery for cervical spinal cord injury at Stanford University. The grant, awarded on August 1, 2024, with a completion date of July 31, 2027, will support innovative research to develop advanced medical treatments for this condition. As a leading research institution,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...
The Department of the Army Medical Command awarded a $1.5 million Project Grant to the University of Miami to support research on the "Safety and Efficacy of Autologous Human Schwann Cell (AHSC) Augmentation in Severe Peripheral Nerve Injury (PNI)." The grant period runs from September 30, 2022 to September 29, 2026. The research aims to investigate using a patient's own Schwann cells, which support nerve growth, to treat severe injuries to peripheral nerves. This work aligns with...
The U.S. Department of Defense's Defense Health Agency awarded a $2,385,311 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant will fund a 4-year study to evaluate the efficacy of a criteria-based clinical pathway for rehabilitation of shoulder injuries. The project involves technical expertise from sub-awardees the University of Southern California and The Geneva Foundation. Key...
The Defense Health Agency awarded a $963,110 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "SAFETY OF TRANSCUTANEOUS ELECTRICAL STIMULATION POTENTIATING RECOVERY IN ACUTE SPINAL CORD INJURY SYNDROMES (STEP-RAISE)", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
The U.S. Defense Health Agency awarded a $325,142 Project Grant to Onward Medical Inc. under the Military Medical Research and Development program (CFDA 12.420) to develop a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The grant period runs from September 1, 2025 to August 31, 2028. This project aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions...
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
This federal Project Grant award of $1,868,800.00, provided by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the effect of cardiocentric hemodynamic management on cardiovascular outcomes for individuals with acute cervical spinal cord injury. The award was made to the University of British Columbia's Research Services division, which has a history of conducting advanced biomedical research for federal...
The Defense Health Agency awarded a $3,977,103 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Washington University to conduct a 4-year clinical trial on nerve transfer surgeries to improve upper limb function and quality of life for patients with high-level cervical spinal cord injuries. The study aims to address critical information gaps on the use of nerve transfer procedures in this patient population. The project will be executed through a multi-site collaboration, with The Washington University serving as the Clinical Coordinating Center and providing $55,000 fixed-fee sub-awards to sites like the University of Michigan, Stanford University, University of Miami, and Johns Hopkins University to enroll and monitor patients over the course of the study.